Pharma reps Physicians Sales 
World of DTC Marketing
JANUARY 11, 2022
As HCPs get more digitally savvy, pharma marketers should understand that engaging physicians through channels and time of their preference with content relevant to the individual customer. Since the beginning of the pandemic, the interactions of traditional in-person pharma representatives have declined steeply.
PM360
SEPTEMBER 28, 2022
For life sciences commercial teams, effectively engaging physicians and supporting them with education on the evolving science around products and conditions requires a deep understanding of physician content needs and channel preferences. physicians across 15 specialties, treating more than 95 conditions. Among all U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
MAY 25, 2023
In conjunction with CMI Media Group’s international expansion beyond the United States, we conducted research and published a report in partnership with Medscape which delved into the media habits of physicians across the EU5 countries: France, Germany, Italy, Spain, and the United Kingdom.
World of DTC Marketing
JANUARY 18, 2021
Of the 75% of physicians who preferred in-person visits from Medtech representatives prior to Covid-19, 47% now prefer virtual exchanges or less-frequent visits. Furthermore, only 10% of physicians had met with a pharmaceutical company representative in a hospital. no pharmaceutical reps). The Challenges for Pharma.
Evolve Your Success
MAY 9, 2023
You can be a mom and still be a top performing medical sales professional. Not many moms figure in our industry for now, but those who do really excel at their job. — Watch the episode here Listen to the podcast here A Mother’s 20 Years Experience In Medical Device Sales With Dena Lewis We have with us Dena Lewis. How are you?
Cesare Ferrari
JULY 22, 2024
One of the challenges in medical sales is disseminating the right messages to the right doctors at the right time. Also, already before the COVID-19 pandemic, many physicians began to restrict visits from pharma reps in some way, and the majority of offices had variable access policies governing pharma rep visits.
Pharma Marketing Network
OCTOBER 13, 2020
Mark Bard: I think the most challenging aspect of the current situation is the inability of anyone – patient, physician, payor, or pharma – to truly predict how long it will take for various parts of the system to get to what becomes the steady state – a new way of operating, the new normal. How does the situation impact pharma?
Expert insights. Personalized for you.
235 
Let's personalize your content